160 related articles for article (PubMed ID: 37300293)
1. Intravenous Transplantation of Adipose-Derived Mesenchymal Stem Cells Promoted The Production of Dopaminergic Neurons and Improved Spatial Memory in A Rat Model of Parkinson's Disease.
Hamedi H; Ghorbanian SH; Mirzaeian L; Abrari K; Mozdziak P; Ghorbanian MT
Cell J; 2023 May; 25(5):317-326. PubMed ID: 37300293
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson's disease.
Chen D; Fu W; Zhuang W; Lv C; Li F; Wang X
J Neurosci Res; 2017 Mar; 95(3):907-917. PubMed ID: 27617772
[TBL] [Abstract][Full Text] [Related]
3. GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson's disease.
Hoban DB; Howard L; Dowd E
Neuroscience; 2015 Sep; 303():402-11. PubMed ID: 26166730
[TBL] [Abstract][Full Text] [Related]
4. Opposite effects of bone marrow-derived cells transplantation in MPTP-rat model of Parkinson's disease: a comparison study of mononuclear and mesenchymal stem cells.
Capitelli CS; Lopes CS; Alves AC; Barbiero J; Oliveira LF; da Silva VJ; Vital MA
Int J Med Sci; 2014; 11(10):1049-64. PubMed ID: 25136260
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potentials of human microfluidic encapsulated conjunctival mesenchymal stem cells on the rat model of Parkinson's disease.
Forouzandeh M; Bigdeli MR; Mostafavi H; Nadri S; Eskandari M
Exp Mol Pathol; 2021 Dec; 123():104703. PubMed ID: 34619140
[TBL] [Abstract][Full Text] [Related]
6. Intravenous mesenchymal stem cell administration exhibits therapeutic effects against 6-hydroxydopamine-induced dopaminergic neurodegeneration and glial activation in rats.
Suzuki S; Kawamata J; Iwahara N; Matsumura A; Hisahara S; Matsushita T; Sasaki M; Honmou O; Shimohama S
Neurosci Lett; 2015 Jan; 584():276-81. PubMed ID: 25449872
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of Wharton's jelly-derived mesenchymal stem cells on motor deficits due to Parkinson's disease.
Jalali MS; Sarkaki A; Farbood Y; Azandeh SS; Mansouri E; Ghasemi Dehcheshmeh M; Saki G
Iran J Basic Med Sci; 2021 Sep; 24(9):1173-1181. PubMed ID: 35083003
[TBL] [Abstract][Full Text] [Related]
8. LPA signaling is required for dopaminergic neuron development and is reduced through low expression of the LPA1 receptor in a 6-OHDA lesion model of Parkinson's disease.
Yang XY; Zhao EY; Zhuang WX; Sun FX; Han HL; Han HR; Lin ZJ; Pan ZF; Qu MH; Zeng XW; Ding Y
Neurol Sci; 2015 Nov; 36(11):2027-33. PubMed ID: 26169757
[TBL] [Abstract][Full Text] [Related]
9. BDNF-modified human umbilical cord mesenchymal stem cells-derived dopaminergic-like neurons improve rotation behavior of Parkinson's disease rats through neuroprotection and anti-neuroinflammation.
Jiang Z; Wang J; Sun G; Feng M
Mol Cell Neurosci; 2022 Dec; 123():103784. PubMed ID: 36228967
[TBL] [Abstract][Full Text] [Related]
10. Olfactory mucosa stem cells: An available candidate for the treatment of the Parkinson's disease.
Simorgh S; Alizadeh R; Eftekharzadeh M; Haramshahi SMA; Milan PB; Doshmanziari M; Ramezanpour F; Gholipourmalekabadi M; Seifi M; Moradi F
J Cell Physiol; 2019 Dec; 234(12):23763-23773. PubMed ID: 31173364
[TBL] [Abstract][Full Text] [Related]
11. Heat shock protein 60 affects behavioral improvement in a rat model of Parkinson's disease grafted with human umbilical cord mesenchymal stem cell-derived dopaminergic-like neurons.
Zhao C; Li H; Zhao XJ; Liu ZX; Zhou P; Liu Y; Feng MJ
Neurochem Res; 2016 Jun; 41(6):1238-49. PubMed ID: 26758268
[TBL] [Abstract][Full Text] [Related]
12. Human adipose-derived mesenchymal stem cells improve motor functions and are neuroprotective in the 6-hydroxydopamine-rat model for Parkinson's disease when cultured in monolayer cultures but suppress hippocampal neurogenesis and hippocampal memory function when cultured in spheroids.
Berg J; Roch M; Altschüler J; Winter C; Schwerk A; Kurtz A; Steiner B
Stem Cell Rev Rep; 2015 Feb; 11(1):133-49. PubMed ID: 25120226
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
[TBL] [Abstract][Full Text] [Related]
14. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.
Aponso PM; Faull RL; Connor B
Neuroscience; 2008 Feb; 151(4):1142-53. PubMed ID: 18201835
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of Wharton's jelly-derived Mesenchymal Stromal Cells on behaviors, EEG changes and NGF-1 in rat model of the Parkinson's disease.
Jalali MS; Saki G; Farbood Y; Azandeh SS; Mansouri E; Ghasemi Dehcheshmeh M; Sarkaki A
J Chem Neuroanat; 2021 Apr; 113():101921. PubMed ID: 33600923
[TBL] [Abstract][Full Text] [Related]
16. Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease.
Teixeira FG; Vilaça-Faria H; Domingues AV; Campos J; Salgado AJ
Cells; 2020 Jan; 9(2):. PubMed ID: 32012897
[TBL] [Abstract][Full Text] [Related]
17. Neural metabolite changes in corpus striatum after rat multipotent mesenchymal stem cells transplanted in hemiparkinsonian rats by magnetic resonance spectroscopy.
Fu W; Zheng Z; Zhuang W; Chen D; Wang X; Sun X; Wang X
Int J Neurosci; 2013 Dec; 123(12):883-91. PubMed ID: 23768098
[TBL] [Abstract][Full Text] [Related]
18. Transplanted Wharton's jelly mesenchymal stem cells improve memory and brain hippocampal electrophysiology in rat model of Parkinson's disease.
Jalali MS; Sarkaki A; Farbood Y; Azandeh SS; Mansouri E; Ghasemi Dehcheshmeh M; Saki G
J Chem Neuroanat; 2020 Dec; 110():101865. PubMed ID: 32991967
[TBL] [Abstract][Full Text] [Related]
19. Effects of mesenchymal stem cell on dopaminergic neurons, motor and memory functions in animal models of Parkinson's disease: a systematic review and meta-analysis.
Park JM; Rahmati M; Lee SC; Shin JI; Kim YW
Neural Regen Res; 2024 Jul; 19(7):1584-1592. PubMed ID: 38051903
[TBL] [Abstract][Full Text] [Related]
20. The lentiviral-mediated Nurr1 genetic engineering mesenchymal stem cells protect dopaminergic neurons in a rat model of Parkinson's disease.
Wang X; Zhuang W; Fu W; Wang X; Lv E; Li F; Zhou S; Rausch WD; Wang X
Am J Transl Res; 2018; 10(6):1583-1599. PubMed ID: 30018702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
